Theresa Tse
Chairman at SINO BIOPHARMACEUTICAL LIMITED
Net worth: 2 M $ as of 2024-03-30
Profile
Currently, Theresa Tse is Chairman for Sino Biopharmaceutical Ltd. She is also on the board of 5 other companies. Ms. Tse received an undergraduate degree from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-18 | 4,000,000 ( 0.02% ) | 2 M $ | 2024-03-30 |
Theresa Tse active positions
Companies | Position | Start |
---|---|---|
SINO BIOPHARMACEUTICAL LIMITED | Chairman | 2015-06-29 |
KAROLINSKA DEVELOPMENT AB | Director/Board Member | 2017-11-27 |
Golden Sword Ventures Ltd. | Director/Board Member | - |
Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. | Director/Board Member | - |
Sino Biopharmaceutical (Beijing) Ltd.
Sino Biopharmaceutical (Beijing) Ltd. Miscellaneous Commercial ServicesCommercial Services Sino Biopharmaceutical (Beijing) Ltd. is an investment holding company. Its sole asset is its 33.6% interest in Beijing Tide Pharmaceutical Co., Ltd., a pharmaceutical company established in China with limited liability, which develops, manufactures, and market pharmaceutical products. Sino Biopharmaceutical (Beijing) was founded on December 31, 2007 and is headquartered in Hong Kong. | Director/Board Member | - |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Director/Board Member | - |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Director/Board Member | - |
Chia Tai Life Technology Ltd. | Director/Board Member | - |
Yun On Investment Holding Ltd. | Director/Board Member | - |
░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Theresa Tse
Companies | Position | End |
---|---|---|
░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Theresa Tse
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
TIANJIN BINHAI TEDA LOGISTICS (GROUP) CORPORATION LIMITED | Transportation |
SINO BIOPHARMACEUTICAL LIMITED | Health Technology |
KAROLINSKA DEVELOPMENT AB | Finance |
Private companies | 10 |
---|---|
Beijing Tide Pharmaceutical Co., Ltd.
Beijing Tide Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Tide Pharmaceutical Co., Ltd. engages in research, development, manufacturing and sale of pharmaceutical products. The firm's products include kaifen flurbiprofen axetil injection, kaishi alprostadil injection, kaina beraprost sodium tablet and deyou pronase granules. The company was founded in May 1995 and is headquartered in Beijing, China. | Commercial Services |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. | |
Golden Sword Ventures Ltd. | |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Health Technology |
Beijing Chia Tai Charity Foundation | |
Chia Tai Life Technology Ltd. | |
Yun On Investment Holding Ltd. | |
Sino Biopharmaceutical (Beijing) Ltd.
Sino Biopharmaceutical (Beijing) Ltd. Miscellaneous Commercial ServicesCommercial Services Sino Biopharmaceutical (Beijing) Ltd. is an investment holding company. Its sole asset is its 33.6% interest in Beijing Tide Pharmaceutical Co., Ltd., a pharmaceutical company established in China with limited liability, which develops, manufactures, and market pharmaceutical products. Sino Biopharmaceutical (Beijing) was founded on December 31, 2007 and is headquartered in Hong Kong. | Commercial Services |
France Investment (China 1) Group Ltd.
France Investment (China 1) Group Ltd. Financial ConglomeratesFinance France Investment (China 1) Group Ltd. operates as an investment holding company. The company is headquartered in Hongkong. | Finance |
- Stock Market
- Insiders
- Theresa Tse